Copertina

One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Joachim Holt, Rasmus Michael Sandsdal, Sarah Byberg, Charlotte Janus, Christian Rimer Juhl, Julie Rehné Jørgensen, Bolette Hartmann, Bente Stallknecht, Jens Juul Holst, Sten Madsbad, Simon Birk Kjær Jensen, Signe Sørensen Torekov
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Obesity
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Potent incretin‐based therapy for obesity: A systematic review and meta‐analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety
di: Alberte Laura Oest Müllertz, et al.
Pubblicazione: (2024)

Treat to target in weight management with semaglutide: Real‐world evidence from an eHealth clinic
di: Søren Seier, et al.
Pubblicazione: (2025)

GLP ‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide
di: Katrine D. Galsgaard, et al.
Pubblicazione: (2025)

An Update on GLP‐1 Receptor Agonists
di: Zachary Bloomgarden
Pubblicazione: (2025)

Levodopa Efficacy and GLP ‐1 Receptor Agonists
di: Catherine Martinez, et al.
Pubblicazione: (2026)

GLP ‐1 Receptor Agonists and Acne: Evidence and Inference
di: Marco Rocha, et al.
Pubblicazione: (2026)

Increased gallbladder emptying and reduced GLP ‐1 response in pregnancy with and without gestational diabetes mellitus
di: Ida M. Gether, et al.
Pubblicazione: (2024)

Radiographic Midfacial Volume Changes in Patients on GLP‐1 Agonists
di: Rahul K. Sharma, et al.
Pubblicazione: (2025)

Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder
di: Mette Kruse Klausen, et al.
Pubblicazione: (2025)

Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD
di: Maryam Zafer, et al.
Pubblicazione: (2025)

Acute GIP and GLP ‐1 Administration Exerts Differential Metabolic Effects in Totally Pancreatectomised Individuals
di: Liva S. L. Krogh, et al.
Pubblicazione: (2026)

Impact of GLP‐1 and GLP‐1/GIP Receptor Agonist Weight Loss Post‐Lung Transplant on Lung Allograft Function
di: Spenser E. January, et al.
Pubblicazione: (2025)

Potent and Protease Resistant Azapeptide Agonists of the GLP‐1 and GIP Receptors
di: Tristan C. Dinsmore, et al.
Pubblicazione: (2024)

The Risk of Hypothyroidism With the Use of GLP ‐1 Receptor Agonists in Saudi Arabia
di: Almaha Alfakhri, et al.
Pubblicazione: (2026)

Potent and Protease Resistant Azapeptide Agonists of the GLP‐1 and GIP Receptors
di: Tristan C. Dinsmore, et al.
Pubblicazione: (2024)

GLP ‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?
di: Alina Zgardau, et al.
Pubblicazione: (2025)

Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
di: Roberta Scairati, et al.
Pubblicazione: (2026)

Target Trial Emulations of GLP ‐1 and Dual GLP ‐1/ GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes
di: Alex E. Henney, et al.
Pubblicazione: (2025)

Assessing the Impact of GLP‐1R Agonists in Post‐sinus Surgery Management
di: David Hoying, et al.
Pubblicazione: (2025)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
di: Giorgia Rutigliani, et al.
Pubblicazione: (2026)

Review Article: The Evolving Role of GLP ‐1 Receptor Agonists in Gastroenterology Practice
di: Sydney Pomenti, et al.
Pubblicazione: (2025)

Time‐Related Biases in Observational Studies of GLP ‐1 Agonists and Cancer Risk
di: Fei Lu
Pubblicazione: (2026)

Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
di: Lasin Ozbek, et al.
Pubblicazione: (2026)

How Should We Approach GLP ‐1 Receptor Agonist Users During Endoscopy?
di: Shun Ito, et al.
Pubblicazione: (2025)

9 | GLP‐1 Receptor Agonists in Systemic Lupus Erythematosus: A Scoping Review
Pubblicazione: (2026)

Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
di: Inyoung Hwang, et al.
Pubblicazione: (2026)

Effects of GLP‐1 Receptor Agonists on Paediatric Population in a Real World Setting
di: A. G. Barajas, et al.
Pubblicazione: (2025)

Letter: From Safety to Precision—Optimising the Use of GLP‐1 Receptor Agonists in Gastroenterology
di: Joëlle St‐Pierre, et al.
Pubblicazione: (2026)

The Ozempic Generation: What the Interventional Radiologist Needs to Know About GLP ‐1 Agonists
di: Suhail Wani, et al.
Pubblicazione: (2025)

Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review
di: Miranda K. Branyiczky, et al.
Pubblicazione: (2025)

Reply: Time‐Related Biases in Observational Studies of GLP ‐1 Agonists and Cancer Risk
di: Zhiyuan Cheng, et al.
Pubblicazione: (2026)

Library History Revisited: Research Areas and Methodology.
di: Byberg, Lis
Pubblicazione: (1999)

GLP‐1 and Dual GLP‐1/GIP Receptor Agonists in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta‐Analysis
di: Mushood Ahmed, et al.
Pubblicazione: (2025)

TTE GLP
di: TTE
Pubblicazione: (2024)

Free Fatty Acids and Complex Lipids in Patients With Severe Obesity Treated With Roux‐En‐Y Gastric Bypass: Impact of Diabetes Status
di: Freja Eriksen, et al.
Pubblicazione: (2025)

Annual Prize Lecture 2024: Endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes
di: Jens Juul Holst
Pubblicazione: (2024)

Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP‐1, GIP, and Glucagon Agonists
di: Mohammed Shareef Khan, et al.
Pubblicazione: (2026)

GLP‐1 Agonists as Potential Neuromodulators in Development of Parkinson's Disease: A Nationwide Cohort Study
di: Mads Gamborg, et al.
Pubblicazione: (2025)

Unmasking Aspiration Risks: A Propensity‐Matched Odyssey of GLP‐1 Receptor Agonists and Colonoscopy
di: Puneet Chhabra, et al.
Pubblicazione: (2025)

Weight Loss With GLP ‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis
di: Michael Lim, et al.
Pubblicazione: (2026)